Compare Agilent Technologies Inc (A) vs Caesars Entertainment Inc (CZR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Agilent Technologies Inc vs Caesars Entertainment Inc — how do they compare? Agilent Technologies Inc trades at $149 (market cap $42.22B), while Caesars Entertainment Inc trades at $29.66 (market cap $6.06B). The key difference: Agilent Technologies Inc is far larger — about 7× Caesars Entertainment Inc's market cap, and Agilent Technologies Inc pays a 0.68% dividend while Caesars Entertainment Inc pays none. Which is the better fit depends on your goals.
| A | CZR | |
|---|---|---|
Market Cap | $42.22B | $6.06B |
Sector | Health | Consumer Cyclical |
52-Week High | $157.20 | $30.41 |
52-Week Low | $110.24 | $18.14 |
Enterprise Value | $43.77B | $29.95B |
Dividend Yield | 0.68% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Agilent Technologies (A) trades at $148.72, up 1.88% with strong analyst support (77.5% buy ratings). The stock shows bullish technical momentum above key support levels, supported by consistent revenue around $6.9B and robust profitability with 19.55% net margins. Recent FDA approvals for diagnostic tests and the Biocare Medical acquisition enhance growth prospects in biopharma markets.
Outlook remains positive with a $154.90 consensus price target offering 4% upside, though high P/E of 30.02 poses valuation risk. Key catalysts include Q2 2026 earnings due August 26 and AI-driven lab expansion, while overbought RSI levels near 92 suggest near-term consolidation potential.
Caesars Entertainment (CZR) trades at $30.07, down 0.27% on the day, with a bullish technical signal from moving averages but neutral oscillators. The company reported a Q2 2026 net loss of $0.30 per share, missing estimates, while revenue of $3.0 billion topped expectations. Recent news highlights the pending $5.7 billion acquisition by Tilman Fertitta, which could reshape its ownership structure.
CZR offers value with low P/E and P/S ratios, but persistent net losses and high debt pose risks. The acquisition provides a potential exit near current levels, yet operational challenges and competitive pressures in the gaming sector warrant caution. Analyst consensus is mixed, with 30% buy ratings but 70% hold, reflecting uncertainty around profitability improvements.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Agilent Technologies Inc
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools (45% of fiscal 2021 sales), cross lab (35% of sales consisting of consumables and services related to its life science and applied tools), and diagnostics and genomics (20%). Over half of its sales are generated from the biopharmaceutical, chemical, and energy end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. (34%) and China (20%) representing the largest country concentrations.
Read more on A →About Caesars Entertainment Inc
Caesars Entertainment includes around 50 domestic gaming properties across Las Vegas (50% of 2021 EBITDAR before corporate and digital expenses) and regional (63%) markets. Additionally, the company hosts managed properties and digital assets, the later of which produced material EBITDA losses in 2021. Caesars' U.S. presence roughly doubled with the 2020 acquisition by Eldorado, which built its first casino in Reno, Nevada, in 1973 and expanded its presence through prior acquisitions to over 20 properties before merging with legacy Caesars. Caesars' brands include Caesars, Harrah's, Tropicana, Bally's, Isle, and Flamingo. Also, the company owns the U.S. portion of William Hill (it plans to sell the international operation in 2022), a digital sports betting platform.
Read more on CZR →
